Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.

Autor: de Moraes, Francisco Cezar Aquino1 (AUTHOR) francisco.cezar2205@gmail.com, Pasqualotto, Eric2 (AUTHOR), Chavez, Matheus Pedrotti2 (AUTHOR), Ferreira, Rafael Oliva Morgado2 (AUTHOR), De Castria, Tiago Biachi3,4 (AUTHOR), Burbano, Rommel Mario Rodríguez5 (AUTHOR)
Zdroj: BMC Cancer. 2/21/2024, Vol. 24 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje